Patients with TEs N: 10 | Patients without TEs N: 125 | P value | Patients with bleeding events N: 12 | Patients without bleeding events N: 123 | P value | |
---|---|---|---|---|---|---|
Age, years | 49.3 ± 13.8 | 51.7 ± 13.7 | 0.600 | 48.0 ± 9.1 | 51.8 ± 14.1 | 0.356 |
Gender, male (%) | 4 (40.0) | 45 (36.0) | 1.0 | 4 (33.3) | 45 (36.6) | 1.0 |
Atrial fibrillation, n (%) | 8 (80) | 63 (50.4) | 0.101 | 7 (58.3) | 64 (52) | 0,768 |
Hypertension, n (%) | 5 (50) | 44 (35.2) | 0.496 | 4 (33.3) | 45 (36.6) | 1.0 |
Diabetes mellitus, n (%) | 0 | 17 (13.6) | 0.361 | 1 (8.3) | 16 (13) | 1.0 |
Smoking, n (%) | 3 (37.5) | 28 (24.6) | 0.418 | 4 (33.3) | 27 (24.5) | 0.498 |
Neurological dysfunction, n (%) | 2 (20) | 6 (4.8) | 0.109 | 3 (25) | 5 (4.1) | 0.024 |
Follow-up Time, months | 47.1 ± 30.7 | 39.0 ± 30.5 | 0.439 | 53.2 ± 39.4 | 38.3 ± 30.4 | 0.117 |
Mean LVEF, % | 55.9 ± 10.2 | 53.9 ± 9.1 | 0.514 | 54.0 ± 12.9 | 54.0 ± 8.9 | 0.984 |
Left Atrium, cm | 5.6 ± 1.1 | 5.5 ± 1.0 | 0.799 | 5.7 ± 0.9 | 5.5 ± 1.0 | 0.642 |
sPAP, mmHg | 44.1 ± 12.9 | 42.3 ± 13.5 | 0.692 | 41.9 ± 12.5 | 42.5 ± 13.5 | 0.881 |
Hemoglobin, g/dL | 12.7 ± 1.1 | 13.0 ± 1.6 | 0.512 | 13.2 ± 1.4 | 13.0 ± 1.7 | 0.587 |
Platelet, ×103/μL | 211 ± 63 | 218 ± 77 | 0.769 | 259 ± 57 | 214 ± 76 | 0.051 |
Creatinine, mg/dL | 0.8 ± 0.2 | 1.2 ± 1.2 | 0.283 | 0.9 ± 0.2 | 1.2 ± 1.2 | 0.457 |
Mean INR level | 2.1 ± 0.4 | 2.4 ± 0.5 | 0.022 | 2.4 ± 0.4 | 2.7 ± 0.5 | 0.016 |